Anticholinergic antispasmodic

2 marketed 1 in Phase 3

This page covers all Anticholinergic antispasmodic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Muscarinic acetylcholine receptors, Muscarinic acetylcholine receptors (M1-M5).

Targets

Muscarinic acetylcholine receptors · Muscarinic acetylcholine receptors (M1-M5)

Marketed (2)

Phase 3 pipeline (1)